The Cancer Informatics Core was established to meet the growing needs for informatics and computational support for high throughput biomedical research at a systems biology level. The goal of this core is to facilitate biomedical and translational research at Moffitt by providing methods and tools to record, integrate, manage, analyze and visualize various biomedical, behavioral and clinical data, as well as analyzing data, and deploying caBIG tools to share results with the cancer research community. Services provided include consultation, data mining, data integration, data analysis, database development, web application development, computational tool development, and user training. Such services penetrate the whole process of research projects: initial consultation and data mining that assists in the formation of research hypotheses and preparation of grant application;assisting with experimental design;developing informatics tools to collect and manage heterogeneous data;integrating laboratory data with clinical, behavioral and biological data;performing data analysis and manuscript preparation. The core supports other core facilities by developing databases and tools for computation, visualization and annotation of experimental data. The third type of services involves implementing caBlG infrastructure and application tools so that researchers can share data readily with other cancer centers that implemented the same informatics infrastructure. Training investigators to use informatics and computational tools is also a key service. Since the last review, the core has undergone significant growth under new leadership and has supported numerous research projects for faculty in basic biomedical research, drug discovery, population science and experimental therapeutics. The core also enhanced or developed many tools for searching, analyzing or visualizing proteomics data for the Proteomics Core, and implemented computational pipelines for microarray data processing and quality control for the Molecular Genomics Core. Applications within the caBIG toolset, including caArray, caTissue, caGWAS and GenePattern, have been installed. The Core requests CCSG Support of $291,002, which is 12% of its operational budget. 90% of usage has supported Moffitt members with the remaining 10% for development of infrastructure and development for other cores.

Public Health Relevance

The Cancer Informatics Core plays a critical role in the research activities of Moffitt investigators. With the advancement and adoption of high-throughput technologies in increasingly complex biomedical research, biomedical informatics support is essential. Dedicated and ad hoc consultations have been conducted for faculty members preparing grant proposals. Such early involvement helps investigators form clear hypotheses, design cost-effective experiments, and plan complex data management and analysis strategies

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-16
Application #
8613453
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
16
Fiscal Year
2014
Total Cost
$165,728
Indirect Cost
$67,373
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Chung, Brile; Stuge, Tor B; Murad, John P et al. (2014) Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis. Cell Rep 8:871-82
Charbonneau, Bridget; Block, Matthew S; Bamlet, William R et al. (2014) Risk of ovarian cancer and the NF-*B pathway: genetic association with IL1A and TNFSF10. Cancer Res 74:852-61
Unrod, Marina; Simmons, Vani N; Sutton, Steven K et al. (2014) A randomized clinical trial of self-help intervention for smoking cessation: research design, interventions, and baseline data. Contemp Clin Trials 38:284-90
Osorio, Ana; Milne, Roger L; Kuchenbaecker, Karoline et al. (2014) DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS Genet 10:e1004256
Padron, Eric; Yoder, Sean; Kunigal, Sateesh et al. (2014) ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia. Blood 123:3675-7
Hampras, Shalaka S; Viscidi, Raphael P; Helzlsouer, Kathy J et al. (2014) Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomas. Cancer Epidemiol Biomarkers Prev 23:2591-6
Chen, Ning; Chon, Hye Sook; Xiong, Yin et al. (2014) Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel. Oncol Rep 31:376-83
Molife, L Rhoda; Yan, Li; Vitfell-Rasmussen, Joanna et al. (2014) Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors. J Hematol Oncol 7:1
Carvalho, Renato S; Fernandes, Vanessa C; Nepomuceno, Thales C et al. (2014) Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biol Ther 15:840-50
Rizwani, Wasia; Schaal, Courtney; Kunigal, Sateesh et al. (2014) Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells. PLoS One 9:e100888

Showing the most recent 10 out of 108 publications